Janet H. Pollard

624 total citations · 1 hit paper
16 papers, 383 citations indexed

About

Janet H. Pollard is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Epidemiology. According to data from OpenAlex, Janet H. Pollard has authored 16 papers receiving a total of 383 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Pulmonary and Respiratory Medicine, 5 papers in Oncology and 4 papers in Epidemiology. Recurrent topics in Janet H. Pollard's work include Prostate Cancer Treatment and Research (4 papers), Radiopharmaceutical Chemistry and Applications (3 papers) and Neuroendocrine Tumor Research Advances (3 papers). Janet H. Pollard is often cited by papers focused on Prostate Cancer Treatment and Research (4 papers), Radiopharmaceutical Chemistry and Applications (3 papers) and Neuroendocrine Tumor Research Advances (3 papers). Janet H. Pollard collaborates with scholars based in United States, Canada and Germany. Janet H. Pollard's co-authors include Austin R. Pantel, Peter R. Carroll, Barry A. Siegel, Michael A. Gorin, Kenneth L. Gage, Michael J. Morris, Frédéric Pouliot, David Josephson, Jeffrey Y.C. Wong and Morand Piert and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Clinical Cancer Research.

In The Last Decade

Janet H. Pollard

15 papers receiving 379 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Diagnostic Performance of 18F-DCFPyL-PET/CT in Men with Biochemically Recurrent Prostate Cancer: Results from the CONDOR Phase III, Multicenter Study

2021 237 citations Michael J. Morris, Steven P. Rowe et al. Clinical Cancer Research profile →

Peers

Countries citing papers authored by Janet H. Pollard

Since Specialization

Citations

This map shows the geographic impact of Janet H. Pollard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Janet H. Pollard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Janet H. Pollard more than expected).

Fields of papers citing papers by Janet H. Pollard

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Janet H. Pollard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Janet H. Pollard. The network helps show where Janet H. Pollard may publish in the future.

Co-authorship network of co-authors of Janet H. Pollard

This figure shows the co-authorship network connecting the top 25 collaborators of Janet H. Pollard. A scholar is included among the top collaborators of Janet H. Pollard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Janet H. Pollard. Janet H. Pollard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

#	Work	Indexed citations
1	Inter- and intra-tumoral heterogeneity on [68Ga]Ga-DOTA-TATE/[68Ga]Ga-DOTA-TOC PET/CT predicts response to [177Lu]Lu-DOTA-TATE PRRT in neuroendocrine tumor patients 2024 ·SHILAP Revista de lepidopterología ·(unknown), (unknown), (unknown), (unknown), (unknown), Stephen A. Graves, Janet H. Pollard, Sarah L. Mott, Joseph S. Dillon, Michael M. Graham, Yusuf Menda, Ahmad Shariftabrizi	3
2	PET/CT Imaging in Treatment Planning and Surveillance of Sinonasal Neoplasms 2023 ·Cancers ·Sinan Akay, Janet H. Pollard, (unknown), (unknown), Sedat Giray Kandemirli, Ali Gholamrezanezhad, Yusuf Menda, Michael M. Graham, Ahmad Shariftabrizi	10
3	Grassroots Approach to Forming a Diversity, Equity, and Inclusion Committee in an Academic Radiology Department 2023 ·Radiographics ·(unknown), Janet H. Pollard, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown)	1
4	Diagnostic Performance of 18F-DCFPyL-PET/CT in Men with Biochemically Recurrent Prostate Cancer: Results from the CONDOR Phase III, Multicenter Study breakdown → 2021 ·Clinical Cancer Research ·Michael J. Morris, Steven P. Rowe, Michael A. Gorin, Lawrence Saperstein, Frédéric Pouliot, David Josephson, Jeffrey Y.C. Wong, Austin R. Pantel, Steve Y. Cho, Kenneth L. Gage, Morand Piert, Andrei Iagaru, Janet H. Pollard, Vivien Wong, Jessica Jensen, Tess Lin, Nancy Stambler, Peter R. Carroll, Barry A. Siegel	237
5	Potential for Increasing Uptake of Radiolabeled ⁶⁸ Ga-DOTATOC and ¹²³ I-MIBG in Patients with Midgut Neuroendocrine Tumors Using a Histone Deacetylase Inhibitor Vorinostat 2021 ·Cancer Biotherapy and Radiopharmaceuticals ·Janet H. Pollard, Yusuf Menda, K. D. Zamba, Mark T. Madsen, M. Sue O’Dorisio, Thomas M. O’Dorisio, David Bushnell	11
6	Repeatability of ⁶⁸Ga-PSMA-HBED-CC PET/CT-derived total molecular tumor volume 2021 ·Journal of Nuclear Medicine ·Robert Seifert, (unknown), David Kersting, Wolfgang P. Fendler, Boris Hadaschik, Ken Herrmann, John J. Sunderland, Janet H. Pollard	10
7	18F-Fluciclovine–Avid Mediastinal Lymph Node Metastasis of Cutaneous Malignant Melanoma 2020 ·Clinical Nuclear Medicine ·(unknown), (unknown), Daniel Kahn, Janet H. Pollard	0
8	Nuclear Imaging of Neuroendocrine Tumors 2020 ·Surgical Oncology Clinics of North America ·Janet H. Pollard, (unknown), Yusuf Menda	10
9	Impact of PSMA-targeted imaging with 18F-DCFPyL-PET/CT on clinical management of patients (pts) with biochemically recurrent (BCR) prostate cancer (PCa): Results from a phase III, prospective, multicenter study (CONDOR). 2020 ·Journal of Clinical Oncology ·Michael J. Morris, Peter R. Carroll, Lawrence Saperstein, Frédéric Pouliot, David Josephson, Jeffrey Y.C. Wong, Austin R. Pantel, Steve Y. Cho, Kenneth L. Gage, Morand Piert, Andrei Iagaru, Janet H. Pollard, Vivien Wong, (unknown), Nancy Stambler, Michael A. Gorin, Barry A. Siegel	25
10	Giant vertebral hemangioma masquerading as aggressive tumor: Tc-99m tagged RBC scan can help to solve the diagnostic conundrum! 2019 ·SHILAP Revista de lepidopterología ·(unknown), (unknown), J. F. Hodgson, (unknown), Janet H. Pollard, Yusuf Menda	4
11	Quantitative Test–Retest Measurement of ⁶⁸Ga-PSMA-HBED-CC in Tumor and Normal Tissue 2019 ·Journal of Nuclear Medicine ·Janet H. Pollard, (unknown), Yousef Zakharia, Chad R. Tracy, Kenneth G. Nepple, (unknown), Patrick Breheny, John J. Sunderland	21
12	Incidental diagnosis of sternoclavicular septic arthritis with Moraxella nonliquefaciens 2018 ·IDCases ·Ehab Saad Aldin, (unknown), (unknown), (unknown), Janet H. Pollard	5
13	Comparative analysis of radioactive iodine versus thyroidectomy for definitive treatment of Graves disease 2016 ·Surgery ·(unknown), (unknown), Anna C. Beck, (unknown), Sonia L. Sugg, James R. Howe, Janet H. Pollard, Geeta Lal, Ronald J. Weigel	18
14	Comparative analysis of 99mTc-Tilmanocept (Lymphoseek) vs. 99mTc-Sulfur Colloid Sentinel Node Lymphoscintigraphy and Biopsy 2016 ·Janet H. Pollard, (unknown), Michael M. Graham	2
15	Radiologic manifestations of angioedema 2014 ·Insights into Imaging ·Kousei Ishigami, (unknown), Janet H. Pollard, (unknown), Yutaka Satō	21
16	Internal Jugular Vein Pseudoaneurysm 2014 ·Ultrasound Quarterly ·Janet H. Pollard, Monzer M. Abu‐Yousef	5

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact